| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.032 | 0.6 |